The concentration of soluble interleukin 2 receptor was determined in serum samples from 19 patients with polymyositis/dermatomyositis by an enzyme linked immunosorbent assay (ELISA). The concentration of soluble interleukin 2 receptor in serum samples from patients with polymyositis/dermatomyositis was higher than that in samples from normal subjects. 
The 55 kilodalton chain of human interleukin 2 receptor is released in a soluble form from activated T cells. Soluble interleukin 2 The concentration of soluble interleukin 2 receptor was determined using a commercial kit (T Cell Science, Cambridge, MA, USA) as described previously.6 This kit is a sandwich enzyme linked immunosorbent assay (ELISA) for the detection of soluble interleukin 2 receptor in human serum samples. After the beads coated with monoclonal antibodies to interleukin 2 receptor had been placed in the polyethylene tubes, 200 ,ul serum sample and 200 it peroxidase conjugated monoclonal antibody to interleukin 2 receptor directed against a second epitope on the interleukin 2 receptor molecule were added and the tubes were incubated at room temperature for 90 minutes. After washing several times, o-phenylenediamine (in pH 5 0 citrate buffer and hydrogen peroxide) was added and the sample was left to stand for 30 minutes at room temperature. Finally, 2 5 M sulphuric acid was added to terminate the reaction and the absorbance was determined at 490 nm. The concentration ofsoluble interleukin 2 receptor in the serum samples was determined by a reference curve generated from a set of standards.
The statistical significance of the difference in concentration of soluble interleukin 2 receptor between the patients with polymyositis/ dermatomyositis and normal subjects was obtained using Welch's t test. Results and discussion The figure shows the concentrations of soluble interleukin 2 receptor, assessed by the ELISA, in serum samples from 19 patients with polymyositis/dermatomyositis and 20 normal subjects. The patients with polymyositis/ dermatomyositis had significantly higher concentrations of soluble interleukin 2 receptor, ranging from 75 to 1729-7 U/ml (mean (SD) 638-2 (506-1) U/ml), than the normal subjects, whose range was between 90 and 310 U/ml (155 05 (48 77) U/ml) (p<0 001). The four patients who were not receiving treatment with steroids also had higher concentrations of soluble interleukin 2 receptor (1208, 1363, 785, and 1140 U/ml).
Soluble interleukin 2 receptor is detected in culture supernatants or in serum samples during T cell proliferation. It has therefore been considered that it is a marker of T cell malignancy or activated T cells. 
